Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study

Background Uveal melanoma (UM) is the most common intraocular malignancy in adults. In contrast to cutaneous melanoma (CM), there is no standard therapy, and the efficacy and safety of dual checkpoint blockade with nivolumab and ipilimumab is not well defined.Methods We conducted a retrospective ana...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Arun Singh, Richard Carvajal, Yana G Najjar, Igor Puzanov, Marc Ernstoff, Shailender Bhatia, Katy Tsai, Fei Ding, Zeynep Eroglu, Douglas Johnson, Pauline Funchain, Sunandana Chandra, Ryan Sullivan, Roma Bhatia, Kristina Navrazhina, Kelly Abbate, Barbara Durden, Song Park, Akansha Chowdhary, Jonathan Kennedy, Pankit Vachhani, Joseph Drabick, Tan Xu, Jessica Yang, Daniel Manson, John M Kirkwood, Justine Cohen, Alexander Shoushtari
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2020-05-01
coleção:	Journal for ImmunoTherapy of Cancer
Acesso em linha:	https://jitc.bmj.com/content/8/1/e000331.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!